Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.
about
Varicella-zoster virusMicrobiology laboratory and the management of mother-child varicella-zoster virus infectionEnvelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi networkVaricella zoster vaccines and their implications for development of HSV vaccinesSequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombinationDiscriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplificationIdentification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.VZV meningitis following varicella vaccine.Impact of varicella vaccine on varicella-zoster virus dynamicsPreventing varicella-zoster diseaseReactivated and latent varicella-zoster virus in human dorsal root ganglia.Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCRRapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probesAttenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mousePhylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombinationAsymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccineGenotype of varicella-zoster virus isolates in South Korea.A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.Vaccination to prevent varicella and shingles.Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation.Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain.Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zosterGenotypic analysis of varicella-zoster virus and its seroprevalence in Finland.Nationwide distribution of varicella-zoster virus clades in China.Use of Saliva to Identify Varicella Zoster Virus Infection of the GutReactogenicity to a live attenuated varicella vaccine in Canadian childrenGenetic analysis of varicella-zoster virus in the aqueous humor in uveitis with severe hyphema.Analysis of enzymatic digestion pattern of two open reading frames of Varciella-Zoster genome from Kuwaiti patients using the RFLP technique.Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children.Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolatesMolecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995Prevention of shingles: safety and efficacy of live zoster vaccine.Genotyping of clinical varicella-zoster virus isolates collected in China.Pathogenesis and current approaches to control of varicella-zoster virus infections.Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
P2860
Q24683811-C504192C-4622-4170-B09D-A8988BD1A8FBQ26738745-6A1EE1AE-E410-4B2A-927F-F67131E422FEQ27480319-E5A57C5F-BEBE-4438-9D07-3AF671718F84Q28280820-277406B5-A809-41BB-A04E-B13D82112886Q28732494-20656B31-12C7-4BEE-A9CC-BF00BD0F25B7Q28757353-08556790-B46B-4F60-96E6-4B72158F8B5CQ30229366-51AB8894-9908-4F69-96D4-2F7EB51DE40DQ33562815-D52DC4B0-20C2-41F4-BB68-6E8E3D8293ABQ33591264-B3BA9397-2123-49AC-82D6-C24A88D48E68Q33719386-91080158-B018-4453-8D07-598A6E0F74ECQ33747571-704CD689-954E-4C9E-A1DE-9CAB36C13A21Q33969481-659E5280-7548-4904-9E9E-83277DF90882Q33970458-EDAADD79-FE1E-4A32-AC61-89B09B547D8BQ34069075-F93D3E9B-22AA-489D-8972-8BC6232366C7Q34110122-D68D60F5-56BC-4D6D-B94D-6BBD9CA9C832Q34124505-65126A0A-A504-4A08-8AA6-6CDE834F33C2Q34441066-F9EDF267-35F4-4F64-8512-8BA52F41B94AQ34763836-EFA70EB2-DC01-4120-8D55-0F01867D58C5Q35066632-243A251A-0F75-47B0-BBF8-94A00D624C9DQ35101407-C47C8977-2DF2-49E6-9CE3-9C494282FF9EQ35397475-2B526E51-5194-457B-B05D-F3BA5A8C9144Q35661764-D25EB944-AC84-4C2A-90C4-68A6F9EFABE4Q35690518-E57E9EFD-8AE4-4D71-8EF8-9959C9A74486Q35704301-059FE1DF-F8E6-4720-9433-F736F601A8D3Q35845405-7120A281-AD08-4BA7-A932-68D63628AD12Q35942988-1623B583-FC99-4A85-9DB8-E20ECD18D336Q36095164-29DCF131-42FA-467E-98B1-8563253B4161Q36157980-BEA64425-D951-40CB-A7C0-E051F3EE613DQ36167494-C3A103E1-114F-4ED8-91A6-17C0FAC3EB71Q36170149-68466B3A-6686-43B3-90E8-DF4AD68A338DQ36406646-39F3855E-19B4-4EAE-86ED-B0C02C0A6EC2Q36425938-9278B218-F693-4A8C-8A1A-DAFEA5125DE7Q36519618-590C693D-E5F8-4B2A-A3CD-9FDE3F0968C6Q36541833-CD3D3EE7-C074-49CA-A6C2-F33467BDF471Q36547365-6ADC39CC-AA3B-4005-8587-075F69BDAB55Q36642986-20D20C03-759C-41DB-BB0D-5243A35B2AADQ37191586-9647F846-AEBE-4A11-B7D5-B2E97026E288Q37263293-77B42AFF-2F76-4265-9F16-FE9252361986Q37420420-A6380B24-DEB8-4CC1-B847-06BEFDA9E19BQ37702470-B644EA41-8A0B-4A35-95DB-AE2F81C92CF7
P2860
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Restriction fragment length po ...... ricella-zoster virus isolates.
@ast
Restriction fragment length po ...... ricella-zoster virus isolates.
@en
type
label
Restriction fragment length po ...... ricella-zoster virus isolates.
@ast
Restriction fragment length po ...... ricella-zoster virus isolates.
@en
prefLabel
Restriction fragment length po ...... ricella-zoster virus isolates.
@ast
Restriction fragment length po ...... ricella-zoster virus isolates.
@en
P2093
P2860
P1433
P1476
Restriction fragment length po ...... ricella-zoster virus isolates.
@en
P2093
P2860
P304
P407
P577
1992-02-01T00:00:00Z